Provexis (LSE:PXS) Days Inventory : 173.01 (As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Provexis Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Provexis's Average Total Inventories for the six months ended in Sep. 2023 was £0.24 Mil. Provexis's Cost of Goods Sold for the six months ended in Sep. 2023 was £0.25 Mil. Hence, Provexis's Days Inventory for the six months ended in Sep. 2023 was 173.01.

The historical rank and industry rank for Provexis's Days Inventory or its related term are showing as below:

LSE:PXS' s Days Inventory Range Over the Past 10 Years
Min: 205.19 Med: 341.2 Max: 1168
Current: 205.19

During the past 13 years, Provexis's highest Days Inventory was 1168.00. The lowest was 205.19. And the median was 341.20.

LSE:PXS's Days Inventory is ranked worse than
68.11% of 972 companies
in the Drug Manufacturers industry
Industry Median: 157.72 vs LSE:PXS: 205.19

Provexis's Days Inventory declined from Sep. 2022 (526.44) to Sep. 2023 (173.01).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Provexis's Inventory Turnover for the six months ended in Sep. 2023 was 1.05.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Provexis's Inventory-to-Revenue for the six months ended in Sep. 2023 was 0.61.

Provexis Days Inventory Historical Data

The historical data trend for Provexis's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Days Inventory Chart

Provexis Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Inventory

Get a 7-Day Free Trial

212.30

283.89

264.44

583.21

787.03

Provexis Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Days Inventory	Get a 7-Day Free Trial															642.55	804.66	526.44	518.41	173.01

Competitive Comparison of Provexis's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Provexis's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Provexis's Days Inventory distribution charts can be found below:

* The bar in red indicates where Provexis's Days Inventory falls into.

Provexis Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Provexis's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as

	Days Inventory (A: Mar. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Mar. 2022 )	+	Total Inventories (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0.086	+	0.328)	/	2 )	/	0.096	*	365
=	0.207					/	0.096	*	365
=	787.03

Provexis's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

	Days Inventory (Q: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2023 )	+	Total Inventories (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (0.328	+	0.146)	/	2 )	/	0.25	*	365 / 2
=	0.237					/	0.25	*	365 / 2
=	173.01

Provexis (LSE:PXS) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Provexis's Inventory Turnover for the six months ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.25	/	0.237
	=	1.05

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Provexis's Inventory to Revenue for the six months ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.237	/	0.388
	=	0.61

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Provexis Days Inventory Related Terms

Thank you for viewing the detailed overview of Provexis's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis (LSE:PXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

PXS.GB:UK

Address

2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ

Website

https://www.provexis.com

Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is a patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.